Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis–associated bacteria rather than lactobacilli

Background Bacterial vaginosis (BV) causes genital inflammation and increases HIV risk, whereas a vaginal microbiota dominated by Lactobacillus species is associated with immune quiescence and relative HIV protection. BV treatment reduces genital inflammation, but it is unclear whether this reductio...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Eric Armstrong, Anke Hemmerling, Steve Miller, Kerianne E. Burke, Sara J. Newmann, Sheldon R. Morris, Hilary Reno, Sanja Huibner, Maria Kulikova, Rachel Liu, Emily D. Crawford, Gloria R. Castañeda, Nico Nagelkerke, Bryan Coburn, Craig R. Cohen, Rupert Kaul
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical Investigation 2022-03-01
coleção:	The Journal of Clinical Investigation
Assuntos:	Immunology Microbiology
Acesso em linha:	https://doi.org/10.1172/JCI152930
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!